glucagon receptor retatrutide Research Guide: What the Phase 2 Trial Data Reported (2026) Retatrutide (LY3437943) | MyBioSource

These agents mimic the action of naturally occurring GLP-1, an incretin hormone released from the intestinal L-cells in response to food intake

The FDA does not verify the safety, effectiveness, or quality of compounded medications before they reach patients

Here are some key factors to weigh: First, think about convenience

The goal is not just to lose weight, but to build a foundation for a lifetime of health and wellness

served on scientific advisory panels and/or speakers bureaus and served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer, Bristol-Myers Squibb, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk and Sanofi

Candidates should be in generally good health, motivated to make sustainable lifestyle changes, and looking for a medically supervised alternative to extreme diets or weight-loss medications